» Articles » PMID: 6204547

Primary Prostatic Carcinoid Tumor with Intracytoplasmic Prostatic Acid Phosphatase and Prostate-specific Antigen

Overview
Date 1984 Jul 1
PMID 6204547
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A case of prostatic carcinoid tumor with lymph node metastases is reported. The patient was a 78-year-old male who died in ventricular fibrillation. At autopsy, a 2 X 2 cm, white, irregular tumor was found in the prostate and there were several enlarged para-aortic lymph nodes. Both specimens contained a characteristic carcinoid tumor. Argyrophil stains revealed strong positivity in the primary as well as in the metastatic tumors. Electron micrographs prepared from formalin-fixed tissue demonstrated numerous membrane-bound dense-core granules. Immunoperoxidase-labeled antibodies against both prostatic acid phosphatase and prostate-specific antigen localized in the tumor cells. The ultrastructural and immunohistochemical results support differentiation of the tumor cells toward both prostatic epithelial cells and endocrine cells. We believe that this is the first reported case of a prostatic carcinoid tumor in which specific prostatic tissue markers have been demonstrated in the tumor cells.

Citing Articles

Primary Well-Differentiated Neuroendocrine Tumor/Carcinoid of the Prostate: Case Report and Review of Literature.

Alhamar M, Sethi S, Reuter V, Fine S Int J Surg Pathol. 2024; 32(7):1374-1378.

PMID: 38303155 PMC: 11808340. DOI: 10.1177/10668969241228297.


Neuroendocrine differentiation in the setting of prostatic carcinoma: contemporary assessment of a consecutive series.

Gopalan A, Al-Ahmadie H, Chen Y, Sarungbam J, Sirintrapun S, Tickoo S Histopathology. 2022; 81(2):246-254.

PMID: 35758203 PMC: 9327588. DOI: 10.1111/his.14707.


Neuroendocrine and Aggressive-Variant Prostate Cancer.

Spetsieris N, Boukovala M, Patsakis G, Alafis I, Efstathiou E Cancers (Basel). 2020; 12(12).

PMID: 33339136 PMC: 7765615. DOI: 10.3390/cancers12123792.


Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.

Epstein J, Amin M, Beltran H, Lotan T, Mosquera J, Reuter V Am J Surg Pathol. 2014; 38(6):756-67.

PMID: 24705311 PMC: 4112087. DOI: 10.1097/PAS.0000000000000208.


Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model.

Nandana S, Ellwood-Yen K, Sawyers C, Wills M, Weidow B, Case T Prostate. 2009; 70(6):591-600.

PMID: 19938013 PMC: 2925264. DOI: 10.1002/pros.21093.